E

Esperion Therapeutics
D

ESPR

1.49500
USD
0.01
(0.34%)
مغلق
حجم التداول
171,954
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
296,308,196
أصول ذات صلة
ABBV
ABBV
-0.465
(-0.24%)
190.325 USD
A
ALKS
-0.410
(-1.55%)
26.120 USD
AMGN
AMGN
-2.01
(-0.65%)
306.66 USD
BMY
BMY
-0.525
(-1.07%)
48.455 USD
GILD
GILD
3.000
(2.65%)
116.210 USD
JNJ
JNJ
-1.240
(-0.73%)
168.350 USD
MRK
MRK
0.570
(0.68%)
84.730 USD
PFE
PFE
-0.555
(-2.19%)
24.810 USD
REGN
REGN
-1.20
(-0.21%)
563.22 USD
المزيد
الأخبار المقالات

العنوان: Esperion Therapeutics

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.